IMPACT OF HEALTH INSURANCE BENEFIT DESIGN ON GENERIC DRUG USE IN THE UNITED STATES- A SYSTEMATIC REVIEW
Author(s)
Mishuk AU1, Qian J2, Garza KB2, Hansen RA1
1Harrison School of Pharmacy, Department of Health Outcomes Research and Policy, Auburn University, Auburn, AL, USA, 2Auburn University Harrison School of Pharmacy, Auburn, AL, USA
OBJECTIVES: Use of generic drugs can reduce the growing spending on prescription drugs. In 2014 $227 billion was saved because of generic drugs in the United States. Appropriate policies are imperative to promote the use of generics. This study aimed to understand the influence of health insurance benefit design (copayment, coinsurance, and deductible) on generic drug use. METHODS: We systematically searched the literature between January 2006 and September 2016 using PubMed and Business Source Premier for potentially relevant studies. The search was limited to articles written in English, with human subjects, and conducted in the United States. The PRISMA guideline was used for reporting of evidence. RESULTS: 125 articles were identified and
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PHP25
Topic
Health Policy & Regulatory, Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior, Pricing Policy & Schemes
Disease
Multiple Diseases
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now